According to Biotest 's latest financial reports the company's current earnings are HK$0.77 Billion. In 2023 the company made an earning of HK$1.21 Billion, an increase over its 2022 earnings that were of -HK$89.32 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | HK$0.75 B | -38.04% |
2023 | HK$1.21 B | -1455.72% |
2022 | -HK$89.32 Million | -79.44% |
2021 | -HK$0.44 Billion | 359.41% |
2020 | -HK$94.57 Million | -213.86% |
2019 | HK$83.05 M | -20.6% |
2018 | HK$0.10 B | -135.69% |
2017 | -HK$0.3 Billion | -139.86% |
2016 | HK$0.73 B | -227.25% |
2015 | -HK$0.58 Billion | -199.09% |
2014 | HK$0.58 B | 5.24% |
2013 | HK$0.55 B | 29.54% |
2012 | HK$0.42 B | -35.34% |
2011 | HK$0.66 B | 28.46% |
2010 | HK$0.51 B | -31.44% |
2009 | HK$0.75 B |